Published Date: 04 Mar 2023
Germany: A recent study shows that female hormone therapy increases the risk of cerebral hemorrhage in patients with cerebral hemorrhage.
Read Full NewsVistagen Therapeutics said on Tuesday its experimental anxiety disorder drug failed to meet the main goal of a late-stage trial testing its ability to reduce symptoms in...
Combining mammography AI, polygenic, and clinical risk models improves 10-year breast cancer risk prediction compared with any single model.
1.
Housing aid linked to lower medical financial hardship among US renters with cancer
2.
Modified personalized cancer vaccine generates powerful immune response
3.
Cancer research in the US is world class. With the government pulling out, its future is uncertain
4.
For fit patients with CLL, frontline venetoclax-ibrutinib improves survival.
5.
Can Concurrent Boost Safely Shorten Breast Cancer Radiation?
1.
A Novel Gemcitabine-Releasing Intravesical System for Intermediate-Risk Non-Muscle-Invasive Bladder Cancer
2.
Bispecific Antibodies in Hematologic Malignancies: Mechanisms, Clinical Applications, and Future Directions
3.
Contemporary Models in Oncology for Healthcare Excellence
4.
Trends in Incidence, Care, and Surgery for Medullary Thyroid Cancer: A Review
5.
Practical Applications in Hematology Across Clinical Settings
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Efficient Management of First line ALK-rearranged NSCLC - Part IV
2.
The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation